Equities

ACADIA Pharmaceuticals Inc

ACADIA Pharmaceuticals Inc

Actions
  • Price (EUR)15.84
  • Today's Change1.25 / 8.57%
  • Shares traded50.00
  • 1 Year change-27.34%
  • Beta--
Data delayed at least 15 minutes, as of Nov 08 2024 07:08 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments439417521
Total Receivables, Net1026365
Total Inventory366.647.88
Prepaid expenses392124
Other current assets, total------
Total current assets616508618
Property, plant & equipment, net566266
Goodwill, net------
Intangibles, net65--0
Long term investments------
Note receivable - long term------
Other long term assets5.101310
Total assets749588700
LIABILITIES
Accounts payable18136.88
Accrued expenses23711389
Notes payable/short-term debt000
Current portion long-term debt/capital leases------
Other current liabilities, total------
Total current liabilities25412696
Total long term debt000
Total debt000
Deferred income tax------
Minority interest------
Other liabilities, total636263
Total liabilities317187159
SHAREHOLDERS EQUITY
Common stock0.020.020.02
Additional paid-in capital2,8632,7712,695
Retained earnings (accumulated deficit)(2431)(2370)(2154)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total0.02(0.98)(0.19)
Total equity432400541
Total liabilities & shareholders' equity749588700
Total common shares outstanding165162161
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.